C
C4 Therapeutics D
D
CCCC
1.41000
USD
-0.03
(-1.74%)
مغلق
حجم التداول
32,637
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
100,119,987
العنوان: C4 Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harnessthe body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.